SCOTT Gottlieb, (pictured) has announced his resignation from the role of commissioner of the US Food and Drug Administration (FDA) after almost two years in the role.
Gottlieb is a physician, medical policy expert, and public health advocate who previously served as the FDA's Deputy Commissioner for Medical and Scientific Affairs and before that, as a senior advisor to the FDA Commissioner.
Under Gottlieb's leadership, the FDA has cracked down on an "epidemic" of teenagers using electronic cigarettes, as well as other measures to reduce smoking.
Gottlieb was also widely recognised for his work modernising research tech and strategies used to advance new drugs.
President Trump tweeted, "Scott has helped us to lower drug prices, get a record number of generic drugs approved and onto the market, and so many other things. He and his talents will be greatly missed!"
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Mar 19
